Novo Nordisk slashes 9,000 jobs in fat jab battle: Ozempic and Wegovy maker slims down after sales hit

The Danish pharma giant outlined proposals to shed around 11% of its 78,400-strong workforce amid stiff competition from Mounjaro maker Eli Lilly.